Antonella F Simonetti
Overview
Explore the profile of Antonella F Simonetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
240
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Arroyo-Huidobro M, Fontanet N, Cordomi C, Simonetti A, Perez-Lopez C, Abelenda-Alonso G, et al.
Eur Geriatr Med
. 2024 Oct;
15(5):1477-1487.
PMID: 39425809
Objective: This study aimed to describe the clinical presentation of COVID-19 in hospitalized patients aged 80 or above and to identify predictors for death and complications throughout the epidemic waves...
2.
Escrihuela-Vidal F, Chico C, Borjabad Gonzalez B, Vazquez Sanchez D, Lerida A, De Blas Escudero E, et al.
J Antimicrob Chemother
. 2024 Aug;
79(11):2858-2866.
PMID: 39212166
Background: Although a significant number of cases of Staphylococcus aureus bacteraemia (SAB) are managed at non-referral community hospitals, the impact of a bundle-of-care intervention in this setting has not yet...
3.
Viasus D, Simonetti A, Nonell L, Vidal O, Meije Y, Ortega L, et al.
Biomedicines
. 2023 Feb;
11(2).
PMID: 36830965
(1) Background: Information regarding gene expression profiles and the prognosis of community-acquired pneumonia (CAP) is scarce. We aimed to examine the differences in the gene expression profiles in peripheral blood...
4.
Pallares N, Tebe C, Abelenda-Alonso G, Rombauts A, Oriol I, Simonetti A, et al.
Infect Dis Ther
. 2022 Dec;
12(1):273-289.
PMID: 36495405
Introduction: The profiles of patients with COVID-19 have been widely studied, but little is known about differences in baseline characteristics and in outcomes between subjects with a ceiling of care...
5.
Viasus D, Simonetti A, Estupinan-Bohorquez A, Carratala J
Eur J Clin Invest
. 2020 Dec;
51(6):e13480.
PMID: 33350464
Introduction: Studies have suggested that an inappropriate inflammatory response is a major cause of treatment failure and mortality in patients with community-acquired pneumonia (CAP). We aimed to determine the effect...
6.
Oriol I, Sabe N, Simonetti A, Llado L, Manonelles A, Gonzalez J, et al.
Transpl Int
. 2017 May;
30(9):903-913.
PMID: 28500792
To analyse trends in the aetiology, treatment and outcomes of bloodstream infection (BSI) within the first year post-transplant over the last 10-year period, we prospectively recorded all episodes of BSI...
7.
Puerta-Alcalde P, Cuervo G, Simonetti A, Gracia-Sanchez L, Ortiz D, Garcia-Vidal C
Infect Dis (Lond)
. 2017 Mar;
49(9):698-701.
PMID: 28298163
No abstract available.
8.
Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia
Viasus D, Simonetti A, Garcia-Vidal C, Niubo J, Dorca J, Carratala J
J Antimicrob Chemother
. 2016 Nov;
72(2):547-553.
PMID: 27798219
Background: Although antibiotic de-escalation is regarded as a measure that reduces selection pressure, adverse drug effects and costs, evidence supporting this practice in community-acquired pneumococcal pneumonia (CAPP) is lacking. Methods:...
9.
Viasus D, Ramos O, Ramos L, Simonetti A, Carratala J
Expert Rev Respir Med
. 2016 Nov;
11(1):5-12.
PMID: 27753516
Community-acquired pneumonia is a major public health problem worldwide. In recent years, there has been an increase in the frequency of resistance to the antimicrobials such as β-lactams or macrolides...
10.
Cuervo G, Simonetti A, Alegre O, Sanchez-Salado J, Podzamczer D
AIDS
. 2016 Aug;
30(14):2253-4.
PMID: 27574795
No abstract available.